🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study provides information on immunogenicity of Nasal Glucagon (AMG504...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2013-09
Trial ID
NCT01959334
Treatments Being Tested
The main purpose of this study is to evaluate the safety of nasal glucagon ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-03
Trial ID
NCT02778100
Treatments Being Tested
The main purpose of this study was to evaluate the safety and tolerability ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-10
Trial ID
NCT02778113
Treatments Being Tested
The purpose of this study was to assess how glucagon administered nasally, ...
Status
Completed
Location
Barbara Davis Center for Diabetes
Start Date
2013-11
Trial ID
NCT01997411
Treatments Being Tested
This study will investigate how the body processes nasal glucagon and the e...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2014-06
Trial ID
NCT02806960
Treatments Being Tested
This study will investigate how the body processes nasal glucagon (NG) and ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2015-01
Trial ID
NCT02806973
Treatments Being Tested
In this study, participants with Type 1 diabetes received insulin through a...
Status
Completed
Location
Algorithme Pharma
Start Date
2012-03
Trial ID
NCT01556594
Treatments Being Tested
The purpose of the study is to learn more about different devices for deliv...
Status
Completed
Location
High Point Clinical Trials Center
Start Date
2018-11-19
Trial ID
NCT03765502
Treatments Being Tested